Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
84,449,125
-
Share change
-
+12,247,023
-
Total reported value
-
$1,847,583,748
-
Put/Call ratio
-
143%
-
Price per share
-
$21.90
-
Number of holders
-
166
-
Value change
-
+$298,192,308
-
Number of buys
-
112
-
Number of sells
-
50
Institutional Holders of Summit Therapeutics Inc. - COM (SMMT) as of Q3 2024
As of 30 Sep 2024,
Summit Therapeutics Inc. - COM (SMMT) was held by
166 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
84,449,125 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, FMR LLC, BlackRock, Inc., PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, MILLENNIUM MANAGEMENT LLC, and abrdn plc.
This page lists
164
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.